APO Research
Talk to an analyst

APO RESEARCH · REPORT

In - Vitro ADME Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global In - Vitro ADME Services Market Analysis and Forecast 2026-2032

21 December 2025209 pages

Choose your research edition.

Industry ResearchIn - Vitro ADME Services Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal In - Vitro ADME Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal In - Vitro ADME Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In - Vitro ADME Services Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal In - Vitro ADME Services Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global In - Vitro ADME Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for In - Vitro ADME Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for In - Vitro ADME Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for In - Vitro ADME Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for In - Vitro ADME Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of In - Vitro ADME Services include Charles River, Labcorp, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec and IQVIA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for In - Vitro ADME Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of In - Vitro ADME Services, also provides the revenue of main regions and countries. Of the upcoming market potential for In - Vitro ADME Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the In - Vitro ADME Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global In - Vitro ADME Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for In - Vitro ADME Services revenue, projected growth trends, production technology, application and end-user industry.

In - Vitro ADME Services Segment by Company

Charles River

Labcorp

Envigo

Curia

Evotec

Bioduro-Sundia

Lonza

WuXi AppTec

IQVIA

Tecan Group

Pharmaron

Shanghai Medicilon

ChemPartner

Joinn Laboratories

RTI International

Eurofins Scientific

Aragen Life Sciences

Sai Life Sciences

In - Vitro ADME Services Segment by Type

Small Molecules

Biologics

In - Vitro ADME Services Segment by End User

Biopharmaceutical Companies

Government and Academic Institutes

Others

In - Vitro ADME Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In - Vitro ADME Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In - Vitro ADME Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In - Vitro ADME Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of In - Vitro ADME Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of In - Vitro ADME Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In - Vitro ADME Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In - Vitro ADME Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Small Molecules Major Player Table 3. Biologics Major Player Table 4. Global In - Vitro ADME Services Market Size Growth Rate by End User (US$ Million), 2021 VS 2025 VS 2032 Table 5. Biopharmaceutical Companies Major Player Table 6. Government and Academic Institutes Major Player Table 7. Others Major Player Table 8. In - Vitro ADME Services Industry Trends Table 9. In - Vitro ADME Services Industry Drivers Table 10. In - Vitro ADME Services Industry Opportunities and Challenges Table 11. In - Vitro ADME Services Industry Restraints Table 12. Global In - Vitro ADME Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global In - Vitro ADME Services Market Size by Region (2021-2026) & (US$ Million) Table 14. Global In - Vitro ADME Services Market Share by Region (2021-2026) Table 15. Global In - Vitro ADME Services Market Size by Region (2027-2032) & (US$ Million) Table 16. Global In - Vitro ADME Services Market Share by Region (2027-2032) Table 17. Global In - Vitro ADME Services Revenue by Players (US$ Million) & (2021-2026) Table 18. Global In - Vitro ADME Services Revenue Market Share by Players (2021-2026) Table 19. Global In - Vitro ADME Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global In - Vitro ADME Services Key Players Headquarters & Area Served Table 21. Global In - Vitro ADME Services Players, Product Type & Application Table 22. Global In - Vitro ADME Services Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global In - Vitro ADME Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global In - Vitro ADME Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global In - Vitro ADME Services Revenue by Type (2021-2026) & (US$ Million) Table 27. Global In - Vitro ADME Services Revenue by Type (2027-2032) & (US$ Million) Table 28. Global In - Vitro ADME Services Revenue Market Share by Type (2021-2026) Table 29. Global In - Vitro ADME Services Revenue Market Share by Type (2027-2032) Table 30. Global In - Vitro ADME Services Revenue by End User 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global In - Vitro ADME Services Revenue by End User (2021-2026) & (US$ Million) Table 32. Global In - Vitro ADME Services Revenue by End User (2027-2032) & (US$ Million) Table 33. Global In - Vitro ADME Services Revenue Market Share by End User (2021-2026) Table 34. Global In - Vitro ADME Services Revenue Market Share by End User (2027-2032) Table 35. Charles River Company Information Table 36. Charles River Business Overview Table 37. Charles River In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Charles River In - Vitro ADME Services Product Portfolio Table 39. Charles River Recent Development Table 40. Labcorp Company Information Table 41. Labcorp Business Overview Table 42. Labcorp In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Labcorp In - Vitro ADME Services Product Portfolio Table 44. Labcorp Recent Development Table 45. Envigo Company Information Table 46. Envigo Business Overview Table 47. Envigo In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Envigo In - Vitro ADME Services Product Portfolio Table 49. Envigo Recent Development Table 50. Curia Company Information Table 51. Curia Business Overview Table 52. Curia In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Curia In - Vitro ADME Services Product Portfolio Table 54. Curia Recent Development Table 55. Evotec Company Information Table 56. Evotec Business Overview Table 57. Evotec In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Evotec In - Vitro ADME Services Product Portfolio Table 59. Evotec Recent Development Table 60. Bioduro-Sundia Company Information Table 61. Bioduro-Sundia Business Overview Table 62. Bioduro-Sundia In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bioduro-Sundia In - Vitro ADME Services Product Portfolio Table 64. Bioduro-Sundia Recent Development Table 65. Lonza Company Information Table 66. Lonza Business Overview Table 67. Lonza In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lonza In - Vitro ADME Services Product Portfolio Table 69. Lonza Recent Development Table 70. WuXi AppTec Company Information Table 71. WuXi AppTec Business Overview Table 72. WuXi AppTec In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. WuXi AppTec In - Vitro ADME Services Product Portfolio Table 74. WuXi AppTec Recent Development Table 75. IQVIA Company Information Table 76. IQVIA Business Overview Table 77. IQVIA In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. IQVIA In - Vitro ADME Services Product Portfolio Table 79. IQVIA Recent Development Table 80. Tecan Group Company Information Table 81. Tecan Group Business Overview Table 82. Tecan Group In - Vitro ADME Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Tecan Group In - Vitro ADME Services Product Portfolio Table 84. Tecan Group Recent Development Table 85. Pharmaron Company Information Table 86. Pharmaron Business Overview Table 87. Pharmaron In - Vitro ADME Services Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Pharmaron In - Vitro ADME Services Product Portfolio Table 89. Pharmaron Recent Development Table 90. Shanghai Medicilon Company Information Table 91. Shanghai Medicilon Business Overview Table 92. Shanghai Medicilon In - Vitro ADME Services Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Shanghai Medicilon In - Vitro ADME Services Product Portfolio Table 94. Shanghai Medicilon Recent Development Table 95. ChemPartner Company Information Table 96. ChemPartner Business Overview Table 97. ChemPartner In - Vitro ADME Services Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. ChemPartner In - Vitro ADME Services Product Portfolio Table 99. ChemPartner Recent Development Table 100. Joinn Laboratories Company Information Table 101. Joinn Laboratories Business Overview Table 102. Joinn Laboratories In - Vitro ADME Services Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Joinn Laboratories In - Vitro ADME Services Product Portfolio Table 104. Joinn Laboratories Recent Development Table 105. RTI International Company Information Table 106. RTI International Business Overview Table 107. RTI International In - Vitro ADME Services Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. RTI International In - Vitro ADME Services Product Portfolio Table 109. RTI International Recent Development Table 110. Eurofins Scientific Company Information Table 111. Eurofins Scientific Business Overview Table 112. Eurofins Scientific In - Vitro ADME Services Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Eurofins Scientific In - Vitro ADME Services Product Portfolio Table 114. Eurofins Scientific Recent Development Table 115. Aragen Life Sciences Company Information Table 116. Aragen Life Sciences Business Overview Table 117. Aragen Life Sciences In - Vitro ADME Services Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Aragen Life Sciences In - Vitro ADME Services Product Portfolio Table 119. Aragen Life Sciences Recent Development Table 120. Sai Life Sciences Company Information Table 121. Sai Life Sciences Business Overview Table 122. Sai Life Sciences In - Vitro ADME Services Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Sai Life Sciences In - Vitro ADME Services Product Portfolio Table 124. Sai Life Sciences Recent Development Table 125. North America In - Vitro ADME Services Revenue by Type (2021-2026) & (US$ Million) Table 126. North America In - Vitro ADME Services Revenue by Type (2027-2032) & (US$ Million) Table 127. North America In - Vitro ADME Services Revenue by End User (2021-2026) & (US$ Million) Table 128. North America In - Vitro ADME Services Revenue by End User (2027-2032) & (US$ Million) Table 129. North America In - Vitro ADME Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America In - Vitro ADME Services Revenue by Country (2021-2026) & (US$ Million) Table 131. North America In - Vitro ADME Services Revenue by Country (US$ Million) & (2027-2032) Table 132. Europe In - Vitro ADME Services Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe In - Vitro ADME Services Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe In - Vitro ADME Services Revenue by End User (2021-2026) & (US$ Million) Table 135. Europe In - Vitro ADME Services Revenue by End User (2027-2032) & (US$ Million) Table 136. Europe In - Vitro ADME Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe In - Vitro ADME Services Revenue by Country (2021-2026) & (US$ Million) Table 138. Europe In - Vitro ADME Services Revenue by Country (US$ Million) & (2027-2032) Table 139. China In - Vitro ADME Services Revenue by Type (2021-2026) & (US$ Million) Table 140. China In - Vitro ADME Services Revenue by Type (2027-2032) & (US$ Million) Table 141. China In - Vitro ADME Services Revenue by End User (2021-2026) & (US$ Million) Table 142. China In - Vitro ADME Services Revenue by End User (2027-2032) & (US$ Million) Table 143. Asia In - Vitro ADME Services Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia In - Vitro ADME Services Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia In - Vitro ADME Services Revenue by End User (2021-2026) & (US$ Million) Table 146. Asia In - Vitro ADME Services Revenue by End User (2027-2032) & (US$ Million) Table 147. Asia In - Vitro ADME Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia In - Vitro ADME Services Revenue by Region (US$ Million) & (2021-2026) Table 149. Asia In - Vitro ADME Services Revenue by Region (US$ Million) & (2027-2032) Table 150. SAMEA In - Vitro ADME Services Revenue by Type (2021-2026) & (US$ Million) Table 151. SAMEA In - Vitro ADME Services Revenue by Type (2027-2032) & (US$ Million) Table 152. SAMEA In - Vitro ADME Services Revenue by End User (2021-2026) & (US$ Million) Table 153. SAMEA In - Vitro ADME Services Revenue by End User (2027-2032) & (US$ Million) Table 154. SAMEA In - Vitro ADME Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. SAMEA In - Vitro ADME Services Revenue by Country (2021-2026) & (US$ Million) Table 156. SAMEA In - Vitro ADME Services Revenue by Country (US$ Million) & (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. In - Vitro ADME Services Image Figure 2. Global In - Vitro ADME Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In - Vitro ADME Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Small Molecules Image Figure 5. Biologics Image Figure 6. Global In - Vitro ADME Services Market Size Growth Rate by End User (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global In - Vitro ADME Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Biopharmaceutical Companies Image Figure 9. Government and Academic Institutes Image Figure 10. Others Image Figure 11. Global In - Vitro ADME Services Market Size (US$ Million) & (2021-2032) Figure 12. Global In - Vitro ADME Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global In - Vitro ADME Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global In - Vitro ADME Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global In - Vitro ADME Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global In - Vitro ADME Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global In - Vitro ADME Services Revenue Market Share by Type (2021-2032) Figure 19. Global In - Vitro ADME Services Revenue by End User (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global In - Vitro ADME Services Revenue Market Share by End User (2021 VS 2025 VS 2032) Figure 21. Global In - Vitro ADME Services Revenue Market Share by End User (2021-2032) Figure 22. North America In - Vitro ADME Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America In - Vitro ADME Services Revenue Share by Type (2021-2032) Figure 24. North America In - Vitro ADME Services Revenue Share by Application (2021-2032) Figure 25. North America In - Vitro ADME Services Revenue Share by Country (2021-2032) Figure 26. United States In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe In - Vitro ADME Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe In - Vitro ADME Services Revenue Share by Type (2021-2032) Figure 31. Europe In - Vitro ADME Services Revenue Share by Application (2021-2032) Figure 32. Europe In - Vitro ADME Services Revenue Share by Country (2021-2032) Figure 33. Germany In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China In - Vitro ADME Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China In - Vitro ADME Services Revenue Share by Type (2021-2032) Figure 43. China In - Vitro ADME Services Revenue Share by Application (2021-2032) Figure 44. Asia In - Vitro ADME Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia In - Vitro ADME Services Revenue Share by Type (2021-2032) Figure 46. Asia In - Vitro ADME Services Revenue Share by Application (2021-2032) Figure 47. Asia In - Vitro ADME Services Revenue Share by Region (2021-2032) Figure 48. Japan In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA In - Vitro ADME Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA In - Vitro ADME Services Revenue Share by Type (2021-2032) Figure 56. SAMEA In - Vitro ADME Services Revenue Share by Application (2021-2032) Figure 57. SAMEA In - Vitro ADME Services Revenue Share by Country (2021-2032) Figure 58. Brazil In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt In - Vitro ADME Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecules
  • Biologics
Applications
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others
Companies covered
  • Charles River
  • Labcorp
  • Envigo
  • Curia
  • Evotec
  • Bioduro-Sundia
  • Lonza
  • WuXi AppTec
  • IQVIA
  • Tecan Group
  • Pharmaron
  • Shanghai Medicilon
  • ChemPartner
  • Joinn Laboratories
  • RTI International
  • Eurofins Scientific
  • Aragen Life Sciences
  • Sai Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 In - Vitro ADME Services Market by Type
  3. 1.2.1 Global In - Vitro ADME Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Small Molecules
  5. 1.2.3 Biologics
  6. 1.3 In - Vitro ADME Services Market by End User
  7. 1.3.1 Global In - Vitro ADME Services Market Size by End User, 2021 VS 2025 VS 2032
  8. 1.3.2 Biopharmaceutical Companies
  9. 1.3.3 Government and Academic Institutes
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 In - Vitro ADME Services Market Dynamics
  1. 2.1 In - Vitro ADME Services Industry Trends
  2. 2.2 In - Vitro ADME Services Industry Drivers
  3. 2.3 In - Vitro ADME Services Industry Opportunities and Challenges
  4. 2.4 In - Vitro ADME Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global In - Vitro ADME Services Market Perspective (2021-2032)
  2. 3.2 Global In - Vitro ADME Services Growth Trends by Region
  3. 3.2.1 Global In - Vitro ADME Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global In - Vitro ADME Services Market Size by Region (2021-2026)
  5. 3.2.3 Global In - Vitro ADME Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global In - Vitro ADME Services Revenue by Players
  2. 4.1.1 Global In - Vitro ADME Services Revenue by Players (2021-2026)
  3. 4.1.2 Global In - Vitro ADME Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global In - Vitro ADME Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global In - Vitro ADME Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global In - Vitro ADME Services Key Players Headquarters & Area Served
  7. 4.4 Global In - Vitro ADME Services Players, Product Type & Application
  8. 4.5 Global In - Vitro ADME Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global In - Vitro ADME Services Market CR5 and HHI
  11. 4.6.3 2025 In - Vitro ADME Services Tier 1, Tier 2, and Tier 3
5 In - Vitro ADME Services Market Size by Type
  1. 5.1 Global In - Vitro ADME Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global In - Vitro ADME Services Revenue by Type (2021-2032)
  3. 5.3 Global In - Vitro ADME Services Revenue Market Share by Type (2021-2032)
6 In - Vitro ADME Services Market Size by Application
  1. 6.1 Global In - Vitro ADME Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global In - Vitro ADME Services Revenue by Application (2021-2032)
  3. 6.3 Global In - Vitro ADME Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Charles River
  2. 7.1.1 Charles River Company Information
  3. 7.1.2 Charles River Business Overview
  4. 7.1.3 Charles River In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Charles River In - Vitro ADME Services Product Portfolio
  6. 7.1.5 Charles River Recent Developments
  7. 7.2 Labcorp
  8. 7.2.1 Labcorp Company Information
  9. 7.2.2 Labcorp Business Overview
  10. 7.2.3 Labcorp In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp In - Vitro ADME Services Product Portfolio
  12. 7.2.5 Labcorp Recent Developments
  13. 7.3 Envigo
  14. 7.3.1 Envigo Company Information
  15. 7.3.2 Envigo Business Overview
  16. 7.3.3 Envigo In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Envigo In - Vitro ADME Services Product Portfolio
  18. 7.3.5 Envigo Recent Developments
  19. 7.4 Curia
  20. 7.4.1 Curia Company Information
  21. 7.4.2 Curia Business Overview
  22. 7.4.3 Curia In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Curia In - Vitro ADME Services Product Portfolio
  24. 7.4.5 Curia Recent Developments
  25. 7.5 Evotec
  26. 7.5.1 Evotec Company Information
  27. 7.5.2 Evotec Business Overview
  28. 7.5.3 Evotec In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Evotec In - Vitro ADME Services Product Portfolio
  30. 7.5.5 Evotec Recent Developments
  31. 7.6 Bioduro-Sundia
  32. 7.6.1 Bioduro-Sundia Company Information
  33. 7.6.2 Bioduro-Sundia Business Overview
  34. 7.6.3 Bioduro-Sundia In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bioduro-Sundia In - Vitro ADME Services Product Portfolio
  36. 7.6.5 Bioduro-Sundia Recent Developments
  37. 7.7 Lonza
  38. 7.7.1 Lonza Company Information
  39. 7.7.2 Lonza Business Overview
  40. 7.7.3 Lonza In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lonza In - Vitro ADME Services Product Portfolio
  42. 7.7.5 Lonza Recent Developments
  43. 7.8 WuXi AppTec
  44. 7.8.1 WuXi AppTec Company Information
  45. 7.8.2 WuXi AppTec Business Overview
  46. 7.8.3 WuXi AppTec In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 WuXi AppTec In - Vitro ADME Services Product Portfolio
  48. 7.8.5 WuXi AppTec Recent Developments
  49. 7.9 IQVIA
  50. 7.9.1 IQVIA Company Information
  51. 7.9.2 IQVIA Business Overview
  52. 7.9.3 IQVIA In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 IQVIA In - Vitro ADME Services Product Portfolio
  54. 7.9.5 IQVIA Recent Developments
  55. 7.10 Tecan Group
  56. 7.10.1 Tecan Group Company Information
  57. 7.10.2 Tecan Group Business Overview
  58. 7.10.3 Tecan Group In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Tecan Group In - Vitro ADME Services Product Portfolio
  60. 7.10.5 Tecan Group Recent Developments
  61. 7.11 Pharmaron
  62. 7.11.1 Pharmaron Company Information
  63. 7.11.2 Pharmaron Business Overview
  64. 7.11.3 Pharmaron In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pharmaron In - Vitro ADME Services Product Portfolio
  66. 7.11.5 Pharmaron Recent Developments
  67. 7.12 Shanghai Medicilon
  68. 7.12.1 Shanghai Medicilon Company Information
  69. 7.12.2 Shanghai Medicilon Business Overview
  70. 7.12.3 Shanghai Medicilon In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Shanghai Medicilon In - Vitro ADME Services Product Portfolio
  72. 7.12.5 Shanghai Medicilon Recent Developments
  73. 7.13 ChemPartner
  74. 7.13.1 ChemPartner Company Information
  75. 7.13.2 ChemPartner Business Overview
  76. 7.13.3 ChemPartner In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 ChemPartner In - Vitro ADME Services Product Portfolio
  78. 7.13.5 ChemPartner Recent Developments
  79. 7.14 Joinn Laboratories
  80. 7.14.1 Joinn Laboratories Company Information
  81. 7.14.2 Joinn Laboratories Business Overview
  82. 7.14.3 Joinn Laboratories In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Joinn Laboratories In - Vitro ADME Services Product Portfolio
  84. 7.14.5 Joinn Laboratories Recent Developments
  85. 7.15 RTI International
  86. 7.15.1 RTI International Company Information
  87. 7.15.2 RTI International Business Overview
  88. 7.15.3 RTI International In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 RTI International In - Vitro ADME Services Product Portfolio
  90. 7.15.5 RTI International Recent Developments
  91. 7.16 Eurofins Scientific
  92. 7.16.1 Eurofins Scientific Company Information
  93. 7.16.2 Eurofins Scientific Business Overview
  94. 7.16.3 Eurofins Scientific In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Eurofins Scientific In - Vitro ADME Services Product Portfolio
  96. 7.16.5 Eurofins Scientific Recent Developments
  97. 7.17 Aragen Life Sciences
  98. 7.17.1 Aragen Life Sciences Company Information
  99. 7.17.2 Aragen Life Sciences Business Overview
  100. 7.17.3 Aragen Life Sciences In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Aragen Life Sciences In - Vitro ADME Services Product Portfolio
  102. 7.17.5 Aragen Life Sciences Recent Developments
  103. 7.18 Sai Life Sciences
  104. 7.18.1 Sai Life Sciences Company Information
  105. 7.18.2 Sai Life Sciences Business Overview
  106. 7.18.3 Sai Life Sciences In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Sai Life Sciences In - Vitro ADME Services Product Portfolio
  108. 7.18.5 Sai Life Sciences Recent Developments
8 North America
  1. 8.1 North America In - Vitro ADME Services Revenue (2021-2032)
  2. 8.2 North America In - Vitro ADME Services Revenue by Type (2021-2032)
  3. 8.2.1 North America In - Vitro ADME Services Revenue by Type (2021-2026)
  4. 8.2.2 North America In - Vitro ADME Services Revenue by Type (2027-2032)
  5. 8.3 North America In - Vitro ADME Services Revenue Share by Type (2021-2032)
  6. 8.4 North America In - Vitro ADME Services Revenue by End User (2021-2032)
  7. 8.4.1 North America In - Vitro ADME Services Revenue by End User (2021-2026)
  8. 8.4.2 North America In - Vitro ADME Services Revenue by End User (2027-2032)
  9. 8.5 North America In - Vitro ADME Services Revenue Share by End User (2021-2032)
  10. 8.6 North America In - Vitro ADME Services Revenue by Country
  11. 8.6.1 North America In - Vitro ADME Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America In - Vitro ADME Services Revenue by Country (2021-2026)
  13. 8.6.3 North America In - Vitro ADME Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe In - Vitro ADME Services Revenue (2021-2032)
  2. 9.2 Europe In - Vitro ADME Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe In - Vitro ADME Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe In - Vitro ADME Services Revenue by Type (2027-2032)
  5. 9.3 Europe In - Vitro ADME Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe In - Vitro ADME Services Revenue by End User (2021-2032)
  7. 9.4.1 Europe In - Vitro ADME Services Revenue by End User (2021-2026)
  8. 9.4.2 Europe In - Vitro ADME Services Revenue by End User (2027-2032)
  9. 9.5 Europe In - Vitro ADME Services Revenue Share by End User (2021-2032)
  10. 9.6 Europe In - Vitro ADME Services Revenue by Country
  11. 9.6.1 Europe In - Vitro ADME Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe In - Vitro ADME Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe In - Vitro ADME Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China In - Vitro ADME Services Revenue (2021-2032)
  2. 10.2 China In - Vitro ADME Services Revenue by Type (2021-2032)
  3. 10.2.1 China In - Vitro ADME Services Revenue by Type (2021-2026)
  4. 10.2.2 China In - Vitro ADME Services Revenue by Type (2027-2032)
  5. 10.3 China In - Vitro ADME Services Revenue Share by Type (2021-2032)
  6. 10.4 China In - Vitro ADME Services Revenue by End User (2021-2032)
  7. 10.4.1 China In - Vitro ADME Services Revenue by End User (2021-2026)
  8. 10.4.2 China In - Vitro ADME Services Revenue by End User (2027-2032)
  9. 10.5 China In - Vitro ADME Services Revenue Share by End User (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia In - Vitro ADME Services Revenue (2021-2032)
  2. 11.2 Asia In - Vitro ADME Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia In - Vitro ADME Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia In - Vitro ADME Services Revenue by Type (2027-2032)
  5. 11.3 Asia In - Vitro ADME Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia In - Vitro ADME Services Revenue by End User (2021-2032)
  7. 11.4.1 Asia In - Vitro ADME Services Revenue by End User (2021-2026)
  8. 11.4.2 Asia In - Vitro ADME Services Revenue by End User (2027-2032)
  9. 11.5 Asia In - Vitro ADME Services Revenue Share by End User (2021-2032)
  10. 11.6 Asia In - Vitro ADME Services Revenue by Country
  11. 11.6.1 Asia In - Vitro ADME Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia In - Vitro ADME Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia In - Vitro ADME Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA In - Vitro ADME Services Revenue (2021-2032)
  2. 12.2 SAMEA In - Vitro ADME Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA In - Vitro ADME Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA In - Vitro ADME Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA In - Vitro ADME Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA In - Vitro ADME Services Revenue by End User (2021-2032)
  7. 12.4.1 SAMEA In - Vitro ADME Services Revenue by End User (2021-2026)
  8. 12.4.2 SAMEA In - Vitro ADME Services Revenue by End User (2027-2032)
  9. 12.5 SAMEA In - Vitro ADME Services Revenue Share by End User (2021-2032)
  10. 12.6 SAMEA In - Vitro ADME Services Revenue by Country
  11. 12.6.1 SAMEA In - Vitro ADME Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA In - Vitro ADME Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA In - Vitro ADME Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst